ReShape Lifesciences, Inc. - Common Stock (RSLS)
0.6151
+0.2729 (79.75%)
NASDAQ · Last Trade: Apr 10th, 1:22 PM EDT
Detailed Quote
Previous Close | 0.3422 |
---|---|
Open | 0.6670 |
Bid | 0.6150 |
Ask | 0.6151 |
Day's Range | 0.5050 - 0.6977 |
52 Week Range | 0.3000 - 29.00 |
Volume | 169,062,314 |
Market Cap | 3.79M |
PE Ratio (TTM) | -0.1928 |
EPS (TTM) | -3.2 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 22,708,889 |
Chart
About ReShape Lifesciences, Inc. - Common Stock (RSLS)
Reshape Lifesciences Inc is a biotechnology company focused on developing innovative medical technologies and solutions for weight management and obesity-related health issues. The company's primary aim is to enhance patient outcomes through its proprietary products, which include minimally invasive procedures designed to aid in weight loss and promote healthier lifestyles. By leveraging advanced engineering and clinical expertise, Reshape Lifesciences seeks to address the growing global health crisis associated with obesity and its complications, ultimately striving to empower individuals to take control of their health through effective interventions. Read More
News & Press Releases
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · April 10, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · April 10, 2025
Via Benzinga · April 10, 2025
ReShape Lifesciences will distribute Motion Informatics' FDA-cleared Stimel-03 rehab device in the U.S., targeting stroke and injury recovery markets.
Via Benzinga · April 10, 2025
Via Benzinga · April 10, 2025
Via Benzinga · April 10, 2025
Via Benzinga · April 10, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · April 9, 2025
Via Benzinga · April 9, 2025
ReShape Enters Exclusive U.S. Distribution Agreement in the Neuromuscular Rehabilitation Market
By ReShape Lifesciences Inc · Via GlobeNewswire · April 9, 2025
Significant Reduction in Overall Operating Expenses of 41.9% in 2024, Excluding M&A Related Expenses, Compared to 2023
By ReShape Lifesciences Inc · Via GlobeNewswire · April 7, 2025
These stocks have an unusual volume in today's session
Via Chartmill · April 7, 2025
Discover the most active stocks in Friday's session. Stay informed about the stocks that are generating the most trading volume!
Via Chartmill · April 4, 2025
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Via Chartmill · April 4, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · April 4, 2025
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via Chartmill · April 2, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Via Chartmill · April 2, 2025
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via Chartmill · April 2, 2025
Via Benzinga · April 2, 2025
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · April 2, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · April 2, 2025
Via Benzinga · April 2, 2025